Veracyte, Inc. (VCYT)
44.65
-3.02
(-6.34%)
USD |
NASDAQ |
Oct 06, 16:00
44.65
0.00 (0.00%)
After-Hours: 20:00
Veracyte Shareholders Equity (Quarterly) : 1.388B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.388B |
| March 31, 2026 | 1.344B |
| December 31, 2025 | 1.310B |
| September 30, 2025 | 1.258B |
| June 30, 2025 | 1.221B |
| March 31, 2025 | 1.195B |
| December 31, 2024 | 1.176B |
| September 30, 2024 | 1.176B |
| June 30, 2024 | 1.133B |
| March 31, 2024 | 1.119B |
| December 31, 2023 | 1.044B |
| September 30, 2023 | 1.054B |
| June 30, 2023 | 1.083B |
| March 31, 2023 | 1.081B |
| December 31, 2022 | 1.075B |
| September 30, 2022 | 1.048B |
| June 30, 2022 | 1.064B |
| March 31, 2022 | 1.085B |
| December 31, 2021 | 1.097B |
| September 30, 2021 | 1.107B |
| June 30, 2021 | 971.18M |
| March 31, 2021 | 974.23M |
| December 31, 2020 | 421.23M |
| September 30, 2020 | 422.72M |
| June 30, 2020 | 226.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 230.42M |
| December 31, 2019 | 239.46M |
| September 30, 2019 | 231.02M |
| June 30, 2019 | 224.24M |
| March 31, 2019 | 83.77M |
| December 31, 2018 | 79.76M |
| September 30, 2018 | 79.42M |
| June 30, 2018 | 25.81M |
| March 31, 2018 | 30.01M |
| December 31, 2017 | 37.22M |
| September 30, 2017 | 42.82M |
| June 30, 2017 | 47.84M |
| March 31, 2017 | 53.35M |
| December 31, 2016 | 59.58M |
| September 30, 2016 | 30.00M |
| June 30, 2016 | 33.75M |
| March 31, 2016 | 43.31M |
| December 31, 2015 | 51.25M |
| September 30, 2015 | 57.81M |
| June 30, 2015 | 65.09M |
| March 31, 2015 | 35.08M |
| December 31, 2014 | 41.37M |
| September 30, 2014 | 48.28M |
| June 30, 2014 | 45.02M |
| March 31, 2014 | 50.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 439.74M |
| Quantum Cyber NV | 4.589M |
| bioAffinity Technologies, Inc. | 3.769M |
| Recursion Pharmaceuticals, Inc. | 915.00M |
| Karyopharm Therapeutics, Inc. | -330.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.486B |
| Total Liabilities (Quarterly) | 97.96M |
| Debt to Equity Ratio | 0.0289 |
| Current Ratio | 9.162 |
| Net Debt Paydown Yield | 0.04% |